EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies

Kefeng Sun, Katarina Ilic, Peixin Xu, Ran Ye, Jingyang Wu, Ivy H Song

Clinical Pharmacology in Drug Development · 2024

DOI: 10.1002/cpdd.1406 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Clinical Pharmacology in Drug Development, 2024. Verfasst von Kefeng Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, MA, USA. Hauptthemen laut MEDLINE: Cross-Over Studies, Food-Drug Interactions, Tablets, Antacids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Development Center Americas, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effect of food composition, tablet crushing, and antacid coadministration on maribavir pharmacokinetics was assessed in 2 Phase 1 studies in healthy adults. In the first, a single maribavir 400‐mg dose was administered under fasting conditions, with a low‐fat/low‐calorie or a high‐fat/high‐calorie meal. In the second, a single maribavir 100‐mg dose was administered under fasting conditions, as a crushed tablet, or as a whole tablet alone or with an antacid. The 90% confidence intervals of the geometric mean ratios were within 80%‐125% for area under the concentration‐time curve (AUC), but not for maximum plasma concentration (C max ) for low‐fat/low‐calorie and high‐fat/high‐calorie meals versus fasting or for whole tablet with antacid versus whole tablet alone. The 90% confidence intervals of the geometric mean ratios for AUC and C max were within 80%‐125% for crushed versus whole tablet. Maribavir median time to C max value in plasma under fed conditions was delayed versus fasting conditions, but there was no statistical difference for crushed versus whole tablet or with versus without antacid. As the antiviral efficacy of maribavir is driven by AUC but not C max , findings suggest that maribavir can be administered with food or antacids or as a crushed tablet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesFood-Drug InteractionsTabletsAntacidsArea Under CurveHealthy VolunteersFastingHumansAdultMaleFemaleYoung AdultMiddle AgedAdministration, OralDrug Compounding

Stichwörter der Autor:innen

antacidcrushed tabletscytomegalovirusfood effectmaribavirpharmacokineticstransplant

Substanzen

TabletsAntacids

Autor:innen und Institutionen

  • Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, MA, USA.
  • Rare Genetics and Hematology Therapeutic Area Unit, Takeda Development Center Americas, Inc., Cambridge, MA, USA.
  • Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc., Cambridge, MA, USA.
  • Bioanalytical Sciences, Takeda Development Center Americas, Inc., Cambridge, MA, USA.

Förderung

  • Takeda Development Center Americas, Inc.

Zitieren

APA

Sun, K., Ilic, K., Xu, P., Ye, R., Wu, J., & Song, I. H. (2024). Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1406

Vancouver

Sun K, Ilic K, Xu P, Ye R, Wu J, Song IH. Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies. Clinical Pharmacology in Drug Development. 2024. doi:10.1002/cpdd.1406

BibTeX
@article{Sun2024,
  author = {Sun, Kefeng and Ilic, Katarina and Xu, Peixin and Ye, Ran and Wu, Jingyang and Song, Ivy H},
  title = {Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2024},
  doi = {10.1002/cpdd.1406}
}
Kostenlos starten →